In an electronic health records-based cohort study, OSA appeared to be an independent risk factor for the later development of Parkinson’s disease and could be modified by early treatment with CPAP.
Read More
Good Sleep Co’s boil-and-bite device enters the market as a temporary mandibular advancement option for snoring, supporting referrals into custom oral-appliance pathways.
Read More
Assignment to New Technology APC 1580 is positive news for Nyxoah’s US commercial rollout.
Read More
This webinar explores evidence-based strategies and innovative tools to enhance screening and diagnosis for women across the lifespan.
Read More
The pharmaceutical giant deepens collaboration with Beacon Biosignals and partners with EnsoData to address challenges in narcolepsy type 1.
Read More